
Metformin (500mg) + Teneligliptin (20mg)
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Medical applications
Moglin M 500mg/20mg Tablet is a combination of metformin and teneligliptin, indicated for the treatment of type 2 diabetes mellitus. This oral antihyperglycemic agent is formulated to provide a sustained reduction in blood glucose levels, thereby mitigating the progression of diabetic complications. The metformin component exerts its therapeutic effect by increasing insulin sensitivity, whereas the teneligliptin component inhibits dipeptidyl peptidase-4 (DPP-4) enzyme activity, thereby preserving and potentiating the action of incretin hormones such as glucagon-like peptide-1 (GLP-1). The fixed-dose combination of metformin 500mg and teneligliptin 20mg in Moglin M Tablet offers a convenient and effective treatment option for patients with type 2 diabetes, with a low risk of hypoglycemia and minimal effect on blood pressure and body weight. As an adjunct to diet and exercise, Moglin M Tablet can be used as a monotherapy or in combination with other oral antihyperglycemic agents or insulin to achieve optimal glycemic control.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Moglin M 500mg/20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Moglin M 500mg/20mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Moglin M 500mg/20mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moglin M 500mg/20mg Tablet may be needed. Please consult your doctor. Use of Moglin M 500mg/20mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Moglin M 500mg/20mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Moglin M 500mg/20mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Moglin M 500mg/20mg Tablet

Metformin (500mg) + Teneligliptin (20mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Medical applications
Moglin M 500mg/20mg Tablet is a combination of metformin and teneligliptin, indicated for the treatment of type 2 diabetes mellitus. This oral antihyperglycemic agent is formulated to provide a sustained reduction in blood glucose levels, thereby mitigating the progression of diabetic complications. The metformin component exerts its therapeutic effect by increasing insulin sensitivity, whereas the teneligliptin component inhibits dipeptidyl peptidase-4 (DPP-4) enzyme activity, thereby preserving and potentiating the action of incretin hormones such as glucagon-like peptide-1 (GLP-1). The fixed-dose combination of metformin 500mg and teneligliptin 20mg in Moglin M Tablet offers a convenient and effective treatment option for patients with type 2 diabetes, with a low risk of hypoglycemia and minimal effect on blood pressure and body weight. As an adjunct to diet and exercise, Moglin M Tablet can be used as a monotherapy or in combination with other oral antihyperglycemic agents or insulin to achieve optimal glycemic control.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Moglin M 500mg/20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Moglin M 500mg/20mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Moglin M 500mg/20mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moglin M 500mg/20mg Tablet may be needed. Please consult your doctor. Use of Moglin M 500mg/20mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Moglin M 500mg/20mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Moglin M 500mg/20mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Moglin M 500mg/20mg Tablet













